SEI Medical Public Co., Ltd.
1.97
THB
-0.03
(-1.50%)
ISIN
THC265010R18
Return %
Stock
S&P 500
1Y
-19.26
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
THB
•
in mil. unless spec.Working Capital
THB
•
in mil. unless spec.Growth Rates
THB
•
in mil. unless spec.Quarterly Revenue
THB
•
in mil. unless spec.Quarterly Earnings Per Share
THB
•
in mil. unless spec.Quarterly Dividends Per Share
THB
•
in mil. unless spec.Company Description
- CEO
- Karn Punyacharoensin
- Sector
- Distribution services
- Industry
- Medical distributors
- Address
- Bangkok Thailand
- IPO Date
- Sep 24, 2024
- Website
- sei.co.th
- Similar Companies
- Business
- SEI Medical Public Company Limited is a Thailand-based distributor and comprehensive service provider of specialized medical devices, healthcare technologies, and scientific laboratory equipment. Founded in 1986 and headquartered in Bangkok, Thailand, the company operates across the domestic healthcare sector, serving public and private hospitals, university medical schools, specialized clinics, and academic research institutions throughout the country. SEI Medical organizes its core commercial offerings into five primary product segments: Endoscopy, comprising gastrointestinal endoscopes, bronchoscopes, otolaryngology instruments, endoscopic video processors, and automated endoscope reprocessing and disinfection systems; Neonatal Patient Care, encompassing infant incubators, infant radiant warmers, neonatal ventilators, phototherapy systems for neonatal hyperbilirubinemia, and non-invasive bilirubin monitors; Surgical Equipment, including operating tables, surgical lighting systems, electrosurgical units, electrocautery devices, and specialized surgical instruments; Aesthetic and Wellness Solutions, featuring non-invasive weight-management devices such as intragastric balloons, skin-tightening platforms, and aesthetic body-contouring technologies; and Scientific Equipment, providing laboratory drying ovens, precision incubators, particle characterization analyzers, and research instruments for chemical and biological analysis. Complementing its product distribution, the company delivers end-to-end technical services, including turnkey equipment installation; comprehensive preventive maintenance, calibration, and engineering repairs; flexible equipment leasing and operating rental solutions; and health-tech integrations, such as artificial intelligence-enabled diagnostic cancer-screening tools and hospital clinical data management systems. In September 2024, SEI Medical completed a significant corporate milestone by listing on Thailand's Market for Alternative Investment (mai) under the ticker symbol SEI through an initial public offering that raised THB 155 million in growth capital. The company is actively deploying these proceeds to procure next-generation medical systems, expand its medical device leasing agreements, grow its recurring maintenance revenue, and introduce high-margin disposable medical supplies and AI-driven clinical software across its national customer base.